Manuel Vázquez Carrera *

Autor invitado por SIIC

El trabajo destaca que los ácidos grasos libres pueden producir algunos de sus efectos prodiabéticos a través de la inducción de IL-6

EL ACIDO PALMITICO AUMENTA LA EXPRESION DE INTERLEUCINA 6 EN CELULAS MUSCULARES ESQUELETICAS

Los resultados de este estudio sugieren que la IL-6 puede mediar parte de los efectos del palmitato sobre la sensibilidad a la insulina.

*Manuel Vázquez Carrera
describe para SIIC los aspectos relevantes de su trabajo
PALMITATE-INDUCED INTERLEUKIN 6 PRODUCTION IS MEDIATED BY PROTEIN KINASE C AND NUCLEAR-FACTOR KAPPAB ACTIVATION AND LEADS TO GLUCOSE TRANSPORTER 4 DOWN-REGULATION IN SKELETAL MUSCLE CELLS
Institución principal de la investigación
*Unidad de Farmacología, Facultad de Farmacia, Universidad de Barcelona, Barcelona, España, Barcelona, España
Imprimir nota

Comprar este artículo
Otros artículos escogidos

Referencias bibliográficas
1. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14:173-194.
2. Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X et al. Effects of fat on insulin-stimulated carbohydrate-metabolism in normal men. Journal of Clinical Investigation 1991; 88:960-966.
3. Boden G, Chen XH. Effects of fat on glucose-uptake and utilization in patients with non-insulin-dependent diabetes. Journal of Clinical Investigation 1995; 96:1261-1268.
4. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW et.al. Mechanism of free fatty acid-induced insulin resistance in humans. Journal of Clinical Investigation 1996;97:2859-2865.
5. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46:3-10.
6. Bronfman M, Morales MN, Orellana A. Diacylglycerol activation of protein kinase-C is modulated by long-chain acyl-CoA. Biochemical and Biophysical Research Communications 1988; 152:987-992.
7. Nishizuka Y. Protein kinases 5. Protein-kinase-C and lipid signaling for sustained cellular-responses. Faseb Journal 1995; 9:484-496.
8. Schmitz Peiffer C, Browne CL, Oakes ND, Watkinson A, Chisholm DJ, Kraegen EW et al. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 1997; 46:169-178.
9. Ruderman NB, Saha AK, Vavvas D, Witters LA. Malonyl-CoA, fuel sensing, and insulin resistance. American Journal of Physiology-Endocrinology and Metabolism 1999; 276:E1-E18.
10. Heydrick SJ, Ruderman NB, Kurowski TG, Adams HB, Chen KS. Enhanced stimulation of diacylglycerol and lipid-synthesis by insulin in denervated muscle - altered protein-kinase-C activity and possible link to insulin resistance. Diabetes 1991; 40:1707-1711.
11. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999; 48:1270-1274.
12. Cortright RN, Azevedo JL, Zhou Q, Sinha M, Pories WJ, Itani SI et.al. Protein kinase C modulates insulin action in human skeletal muscle. American Journal of Physiology-Endocrinology and Metabolism 2000; 278:E553-E562.
13. Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes 2000; 49:1353-1358.
14. Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003; 278:10297-10303.
15. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40:1286-1292.
16. Kern PA, Ranganathan S, Li CL, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. American Journal of Physiology-Endocrinology and Metabolism 2001; 280:E745-E751.
17. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286:327-334.
18. Starkie RL, Arkinstall MJ, Koukoulas I, Hawley JA, Febbraio MA. Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. Journal of Physiology 2001; 533:585-591.
19. Pedersen BK, Steensberg A, Fischer C, Keller C, Ostrowski K, Schjerling P. Exercise and cytokines with particular focus on muscle-derived IL-6. Exercise Immunology Review 2001; 7:18-31.
20. Carey AL, Lamont B, Andrikopoulos S, Koukoulas I, Proietto J, Febbraio MA. Interleukin-6 gene expression is increased in insulin-resistant rat skeletal muscle following insulin stimulation. Biochemical and Biophysical Research Communications 2003; 302:837-840.
21. Kosmidou I, Vassilakopoulos T, Xagorari A, Zakynthinos S, Papapetropoulos A, Roussos C. Production of interleukin-6 by skeletal myotubes - Role of reactive oxygen species. American Journal of Respiratory Cell and Molecular Biology 2002; 26:587-593.
22. Frost RA, Nystrom GJ, Lang CH. Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2002; 283:R698-R709.
23. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. Faseb Journal 2002; 16:1335-1347.
24. Chavez JA, Knotts TA, Wang LP, Li GB, Dobrowsky RT, Florant GL et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. Journal of Biological Chemistry 2003; 278:10297-10303.
25. Cabrero A, Alegret M, Sánchez RM, Adzet T, Laguna JC, Carrera MV. Increased reactive oxygen species production down-regulates peroxisome proliferator-activated alpha pathway in C2C12 skeletal muscle cells. Journal of Biological Chemistry 2002; 277:10100-10107.
26. Freeman WM, Walker SJ, Vrana KE. Quantitative RT-PCR: pitfalls and potential. Biotechniques 1999; 26:112-115.
27. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian-cells. Nucleic Acids Research 1991; 19:2499-2499.
28. Gorski J, Nawrocki A, Murthy M. Characterization of free and glyceride-esterified long chain fatty acids in different skeletal muscle types of the rat. Molecular and Cellular Biochemistry 1998; 178:113-118.
29. Paumen MB, Ishida Y, Muramatsu M, Yamamoto M, Honjo T. Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. Journal of Biological Chemistry 1997; 272:3324-3329.
30. Miyake Y, Kozutsumi Y, Nakamura S, Fujita T, Kawasaki T. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, Isp-1/myriocin. Biochemical and Biophysical Research Communications 1995; 211:396-403.
31. Poynter ME, Daynes RA. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor kappa B signaling, and reduces inflammatory cytokine production in aging. Journal of Biological Chemistry 1998; 273:32833-32841.
32. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee JS et al. Prevention of fat-induced insulin resistance by salicylate. Journal of Clinical Investigation 2001; 108:437-446.
33. Kobayashi E, Ando K, Nakano H, Iida T, Ohno H, Morimoto M et al. Calphostins (Ucn-1028), novel and specific inhibitors of protein kinase-C. 1. Fermentation, isolation, physicochemical properties and biological-activities. Journal of Antibiotics 1989; 42:1470-1474.
34. Sanders JL, Stern PH. Expression and phorbol ester sensitivity of protein kinase C (PKC) isozymes in osteoblasts. Faseb Journal 1996; 10:3923-3923.
35. Bordin L, Priante G, Musacchio E, Giunco S, Tibaldi E, Clari G et al. Arachidonic acid-induced IL-6 expression is mediated by PKC alpha activation in osteoblastic cells. Biochemistry 2003; 42:4485-4491.
36. Ravichandran LV, Esposito DL, Chen J, Quon MJ. Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. Journal of Biological Chemistry 2001; 276:3543-3549.
37. Lagathu C, Bastard JP, Auclair M, Maachi M, Capeau J, Caron M. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochemical and Biophysical Research Communications 2003; 311:372-379.
38. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. Journal of Biological Chemistry 2003; 278:45777-45784.
39. Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002; 51:3391-3399.
40. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 2003; 52:2784-2789.
41. Senn JJ, Klover PJ, Noway I, Furlanetto IR, Mooney RA. Suppressor of cytokine signaling-3 (SOCS-3) is a potential mediator of interleukin-6 dependent insulin resistance. Diabetes 2002; 51:A324-A324.
42. Gauthier Rouviere C, Vandromme M, Tuil D, Lautredou N, Morris M, Soulez M et al. Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts. Molecular Biology of the Cell 1996; 7:719-729.
43. Chin JE, Dickens M, Tavare JM, Roth RA. Overexpression of protein-kinase-C isoenzymes-alpha, beta-I, gamma, and epsilon in cells overexpressing the insulin-receptor - Effects on receptor phosphorylation and signaling. Journal of Biological Chemistry 1993; 268:6338-6347.
44. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and I kappa B-alpha. Diabetes 2002; 51:2005-2011.
45. Ghosh S, Baltimore D. Activation in vitro of Nf-kappa-B by phosphorylation of its inhibitor I-kappa-B. Nature 1990; 344:678-682.